Gentaur Pub

#35969133   2022/08/09 To Up

Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre.

The PLASMIC score is a rapid and inexpensive clinical assessment tool for predicting severe ADAMTS13 deficiency (<10% activity) in patients with suspected thrombotic thrombocytopenic purpura (TTP). The score includes 7 parameters: absence of active cancer, patient not having received stem cell transplant or organ transplant, platelet count <30×10/L, haemolysis, mean corpuscular volume <90 fl, International Normalized Ratio <1.5, and serum creatinine <2 mg/dL.
Antonella Tufano, Mariateresa Polimeno, Beniamino Matani, Giuseppe Cardillo, Filomena Capasso, Rosaria Mormile, Fiorella Paladino, Giovanni Di Minno

2960 related Products with: Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre.